|
difluprednate |
|---|---|
| Trade Name | Durezol |
| Orphan Indication | Endogenous and traumatic anterior uveitis and panuveitis |
| USA Market Approval | USA |
| USA Designation Date | 2008-09-30 00:00:00 |
| Sponsor | Alcon Pharmaceuticals. Ltd.;Route Des Arsenaux 41, 1701 Fribourg (P.O. Box 61); |
